Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Bioethicists Concerned over Japan’s Chimera Embryo Regulations

Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.

Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.

techniques
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Katarina Zimmer | Apr 4, 2019
Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.
Q&A: A 10,000-Genome Milestone for Shared Pediatric Cancer Data  
Q&A: A 10,000-Genome Milestone for Shared Pediatric Cancer Data  
Carolyn Wilke | Apr 1, 2019
Computational biologist Jinghui Zhang of St. Jude realized scientists could work more efficiently with tools and genomic data shared on the cloud.
Infographic: Functional Characterization of Microproteins
Infographic: Functional Characterization of Microproteins
Annie Rathore | Apr 1, 2019
Analyzing protein-protein interactions can shed light on what tiny proteins do in the cell.
Contending with Resistance in Cancer Immunotherapy
Contending with Resistance in Cancer Immunotherapy
Marissa Fessenden | Apr 1, 2019
Researchers describe ways to study how cancer cells evade therapies that harness the immune system.
The Dark Matter of the Human Proteome
The Dark Matter of the Human Proteome
Annie Rathore | Apr 1, 2019
Advances in the functional characterization of newly discovered microproteins hint at diverse roles in health and disease.
Researchers Analyze Epigenetic Signatures to Diagnose Rare Diseases
Researchers Analyze Epigenetic Signatures to Diagnose Rare Diseases
Katarina Zimmer | Mar 28, 2019
A number of rare diseases show unique epigenetic patterns across the genome, a feature researchers have now exploited to build a diagnostic tool.
More Evidence that Humans Do Appear to Create New Neurons in Old AgeMore Evidence that Humans Do Appear to Create New Neurons in Old Age
More Evidence that Humans Do Appear to Create New Neurons in Old Age
Ashley Yeager | Mar 25, 2019
Despite doubts last year about human adult neurogenesis, a study shows even 80-year-olds develop new cells in the hippocampus, but such growth is diminished in patients with Alzheimer’s disease.
Drop Statistical Significance, Scientists Say
Drop Statistical Significance, Scientists Say
Carolyn Wilke | Mar 21, 2019
In service of an arbitrary threshold, p-values often lead researchers to make poorly supported claims and ignore interesting but insignificant results, scientists argue.
Fish and Bees “Talk” with Help from Robot Translators
Fish and Bees “Talk” with Help from Robot Translators
Jef Akst | Mar 20, 2019
Robots integrated into groups of zebrafish and of one-day-old honey bees allow the two species to influence each other’s behavior.
Chemogenetics Method Uses Anti-Smoking Drug to Control Cells
Chemogenetics Method Uses Anti-Smoking Drug to Control Cells
Ruth Williams | Mar 14, 2019
A new set of engineered receptors responds to an FDA-approved drug to provide the most potent chemogenetic toolkit to date.